SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-008228
Filing Date
2017-11-06
Accepted
2017-11-06 16:03:10
Documents
63
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q idra-20170930x10q.htm 10-Q 999159
2 EX-31.1 idra-20170930ex3116aac1a.htm EX-31.1 14223
3 EX-31.2 idra-20170930ex3122a93bf.htm EX-31.2 14234
4 EX-32.1 idra-20170930ex32114c7e0.htm EX-32.1 6714
5 EX-32.2 idra-20170930ex322297a89.htm EX-32.2 6554
  Complete submission text file 0001558370-17-008228.txt   4097755

Data Files

Seq Description Document Type Size
6 EX-101.INS idra-20170930.xml EX-101.INS 844720
7 EX-101.SCH idra-20170930.xsd EX-101.SCH 36443
8 EX-101.CAL idra-20170930_cal.xml EX-101.CAL 42500
9 EX-101.DEF idra-20170930_def.xml EX-101.DEF 112211
10 EX-101.LAB idra-20170930_lab.xml EX-101.LAB 261830
11 EX-101.PRE idra-20170930_pre.xml EX-101.PRE 213420
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31918 | Film No.: 171179516
SIC: 2836 Biological Products, (No Diagnostic Substances)